The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Postow, Merea, named to new positions at MSK

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Michael Postow was named chief of the Melanoma Service in the Division of Solid Tumor Oncology, and Valeria Silva Merea was named director of the Speech and Hearing Center at Memorial Hospital and the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center.

Postow assumed his new role May 24. As chief of the Melanoma Service, he will oversee the ongoing strategic goals of the Melanoma Service to expand the clinical and research programs and activities in melanoma.

Valeria Silva Merea, a surgeon who specializes in caring for people with early laryngeal cancer, and voice, airway, and swallowing disorders, assumed her role in January 2020. She will expand clinical services and MSK’s research program for patients with the full spectrum of speech, voice, airway, swallowing, and hearing disorders.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalTrials & Tribulations

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
By Samuel (Tony) Boova, Eda Holl, LaToya Montgomery, Steve Kussick, Nicholas Kigen, Gilbert Olbara, Festus Muigai Njuguna, Terry Vik and Teresa Loile Lotodo
ClinicalTrials & Tribulations

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
By Enrique Velazquez-Villarreal
Sponsored

The long life of a clinical trial
How JCO sustains landmark oncology research

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 
By Journal of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account